Clinical Trial Detail

NCT ID NCT02283359
Title Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Irinotecan + Selinexor

Age Groups: adult

No variant requirements are available.